• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长链非编码 RNA H19 作为 ceRNA 通过调节 microRNA-107 参与非小细胞肺癌的发生。

LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107.

机构信息

Department of Thoracic Surgery, Jiangdu People's Hospital of Yangzhou City, Yangzhou, China.

出版信息

Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5946-5953. doi: 10.26355/eurrev_201809_15925.

DOI:10.26355/eurrev_201809_15925
PMID:30280776
Abstract

OBJECTIVE

To investigate whether lncRNA H19 can regulate NF1 expression through competitive binding to microRNA-107, thereby participating in the occurrence and development of non-small cell lung cancer (NSCLC).

PATIENTS AND METHODS

Expression levels of H19 and NF1 in NSCLC tissues, paracancerous tissues and NSCLC cell lines were detected by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR). The binding condition of microRNA-107, H19 and NF1 was detected by dual-luciferase reporter gene assay. Corresponding lentiviruses of H19 were constructed. The regulatory effects of H19 on proliferative and migratory abilities of A549 cells were detected by cell counting kit-8 (CCK-8) and transwell assay, respectively. Rescue experiments were conducted to explore the regulatory interaction between H19 and microRNA-107 in A549 cells.

RESULTS

H19 and NF1 were highly expressed in NSCLC tissues and NSCLC cell lines (A549 and HCC823) than those of controls. Overexpressed H19 increased proliferative and migratory abilities of A549 cells. Dual-luciferase reporter gene assay demonstrated that H19 regulates NF1 expression through competitive binding to microRNA-107, thereafter participating in NSCLC development.

CONCLUSIONS

H19 is highly expressed in NSCLC, which promotes NSCLC development by regulating NF1 via competitive binding to microRNA-107.

摘要

目的

研究长链非编码 RNA H19 是否可以通过与 microRNA-107 竞争结合来调节 NF1 的表达,从而参与非小细胞肺癌(NSCLC)的发生和发展。

患者和方法

通过实时荧光定量聚合酶链反应(qRT-PCR)检测 NSCLC 组织、癌旁组织和 NSCLC 细胞系中 H19 和 NF1 的表达水平。通过双荧光素酶报告基因检测 microRNA-107、H19 和 NF1 的结合情况。构建相应的 H19 慢病毒。通过细胞计数试剂盒-8(CCK-8)和 Transwell 实验分别检测 H19 对 A549 细胞增殖和迁移能力的调节作用。进行挽救实验以探讨 H19 和 microRNA-107 在 A549 细胞中的调节相互作用。

结果

H19 和 NF1 在 NSCLC 组织和 NSCLC 细胞系(A549 和 HCC823)中的表达高于对照组。过表达 H19 增加了 A549 细胞的增殖和迁移能力。双荧光素酶报告基因检测表明,H19 通过与 microRNA-107 竞争结合来调节 NF1 的表达,进而参与 NSCLC 的发生发展。

结论

H19 在 NSCLC 中高表达,通过与 microRNA-107 竞争结合来调节 NF1,从而促进 NSCLC 的发展。

相似文献

1
LncRNA H19 serves as a ceRNA and participates in non-small cell lung cancer development by regulating microRNA-107.长链非编码 RNA H19 作为 ceRNA 通过调节 microRNA-107 参与非小细胞肺癌的发生。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5946-5953. doi: 10.26355/eurrev_201809_15925.
2
High expression of lncRNA MEG3 participates in non-small cell lung cancer by regulating microRNA-7-5p.长链非编码 RNA MEG3 的高表达通过调节 microRNA-7-5p 参与非小细胞肺癌。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):5938-5945. doi: 10.26355/eurrev_201809_15923.
3
MicroRNA-19a promotes proliferative and migratory abilities of NSCLC cells by inhibiting PTEN expression.微小RNA-19a通过抑制PTEN表达促进非小细胞肺癌细胞的增殖和迁移能力。
J BUON. 2019 May-Jun;24(3):955-962.
4
LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.长链非编码RNA CASC19通过调控微小RNA-130b-3p促进非小细胞肺癌的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):247-255. doi: 10.26355/eurrev_201908_18654.
5
LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.长链非编码RNA HOXA-AS2通过调控微小RNA-216a-5p促进非小细胞肺癌的恶性进展。
Eur Rev Med Pharmacol Sci. 2019 Aug;23(3 Suppl):264-273. doi: 10.26355/eurrev_201908_18656.
6
LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.长链非编码 RNA HOST2 通过下调 miRNA-621 增强非小细胞肺癌对吉非替尼的耐药性。
Eur Rev Med Pharmacol Sci. 2019 Nov;23(22):9939-9946. doi: 10.26355/eurrev_201911_19560.
7
Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer.长链非编码 RNA H19 诱导的 miR-675-5p 的上调通过靶向非小细胞肺癌中的肿瘤抑制因子 p53 与肿瘤的进展和发展相关。
J Cell Biochem. 2019 Nov;120(11):18724-18735. doi: 10.1002/jcb.29182. Epub 2019 Jun 20.
8
Long non-coding RNA SNHG15 accelerates the progression of non-small cell lung cancer by absorbing miR-211-3p.长链非编码 RNA SNHG15 通过吸收 miR-211-3p 加速非小细胞肺癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1536-1544. doi: 10.26355/eurrev_201902_17112.
9
c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.c-Myc激活的长链非编码RNA H19下调miR-107并促进非小细胞肺癌的细胞周期进程。
Int J Clin Exp Pathol. 2015 Oct 1;8(10):12400-9. eCollection 2015.
10
FOXF2 aggravates the progression of non-small cell lung cancer through targeting lncRNA H19 to downregulate PTEN.FOXF2 通过靶向 lncRNA H19 下调 PTEN 加剧非小细胞肺癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Dec;23(24):10796-10802. doi: 10.26355/eurrev_201912_19782.

引用本文的文献

1
LncRNA H19 acts as a ceRNA to promote glioblastoma malignancy by sponging miR-19b-3p and upregulating SERPINE1.长链非编码RNA H19作为一种竞争性内源RNA,通过吸附miR-19b-3p并上调丝氨酸蛋白酶抑制剂E1(SERPINE1)来促进胶质母细胞瘤的恶性进展。
Cancer Cell Int. 2025 Jun 19;25(1):217. doi: 10.1186/s12935-025-03868-x.
2
Silence of HOTAIR promotes osteogenic differentiation and accelerates distraction osteogenesis by mediating FTO ubiquitination.HOTAIR 的沉默通过介导 FTO 泛素化促进成骨分化并加速牵张成骨。
J Orthop Translat. 2025 Jan 20;50:248-256. doi: 10.1016/j.jot.2024.12.001. eCollection 2025 Jan.
3
Role of long non-coding RNAs in neurofibromatosis and Schwannomatosis: pathogenesis and therapeutic potential.
长链非编码RNA在神经纤维瘤病和神经鞘瘤病中的作用:发病机制与治疗潜力
Epigenomics. 2024 Dec-Dec;16(23-24):1453-1464. doi: 10.1080/17501911.2024.2430170. Epub 2024 Nov 27.
4
Long non-coding RNAs in non-small cell lung cancer: implications for EGFR-TKI resistance.非小细胞肺癌中的长链非编码RNA:对表皮生长因子受体酪氨酸激酶抑制剂耐药性的影响
Front Genet. 2023 Jun 30;14:1222059. doi: 10.3389/fgene.2023.1222059. eCollection 2023.
5
Long noncoding RNA (lncRNA) : An essential developmental regulator with expanding roles in cancer, stem cell differentiation, and metabolic diseases.长链非编码RNA(lncRNA):一种重要的发育调节因子,在癌症、干细胞分化和代谢疾病中发挥着越来越重要的作用。
Genes Dis. 2023 Mar 24;10(4):1351-1366. doi: 10.1016/j.gendis.2023.02.008. eCollection 2023 Jul.
6
Is H19 RNA a Useful Marker of Acromegaly and Its Complications? A Preliminary Study.H19 RNA是肢端肥大症及其并发症的有用标志物吗?一项初步研究。
Biomedicines. 2023 Apr 19;11(4):1211. doi: 10.3390/biomedicines11041211.
7
Long noncoding RNA H19 regulates degeneration and regeneration of injured peripheral nerves.长链非编码RNA H19调节损伤外周神经的退变与再生。
Neural Regen Res. 2023 Aug;18(8):1847-1851. doi: 10.4103/1673-5374.363182.
8
Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.优化的甲状腺转录因子-1 核心启动子驱动的 microRNA-7 表达可有效抑制人非小细胞肺癌细胞的生长。
J Zhejiang Univ Sci B. 2022 Nov 15;23(11):915-930. doi: 10.1631/jzus.B2200116.
9
Targeting non-coding RNA H19: A potential therapeutic approach in pulmonary diseases.靶向非编码RNA H19:肺部疾病的一种潜在治疗方法。
Front Pharmacol. 2022 Sep 16;13:978151. doi: 10.3389/fphar.2022.978151. eCollection 2022.
10
Long Noncoding RNAs in Lung Cancer: From Disease Markers to Treatment Roles.肺癌中的长链非编码RNA:从疾病标志物到治疗作用
Cancer Manag Res. 2022 May 21;14:1771-1782. doi: 10.2147/CMAR.S365762. eCollection 2022.